cyanides has been researched along with Neuroendocrine Tumors in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arvidsson, Y; Bernhardt, P; Elf, AK; Forssell-Aronsson, E; Hofving, T; Johanson, V; Nilsson, O; Wängberg, B | 1 |
Ahlman, H; Arvidsson, Y; Bernhardt, P; Johanson, V; Kölby, L; Nilsson, O; Swärd, C | 1 |
2 other study(ies) available for cyanides and Neuroendocrine Tumors
Article | Year |
---|---|
NAMPT Inhibitor GMX1778 Enhances the Efficacy of 177Lu-DOTATATE Treatment of Neuroendocrine Tumors.
Topics: Animals; Cyanides; Cytokines; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Synergism; Drug Therapy, Combination; Female; Guanidines; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neuroendocrine Tumors; Nicotinamide Phosphoribosyltransferase; Octreotide; Organometallic Compounds; Radiation Tolerance; Radiopharmaceuticals; Treatment Outcome | 2017 |
Antitumoural effects of the pyridyl cyanoguanidine CHS 828 on three different types of neuroendocrine tumours xenografted to nude mice.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cyanides; Female; Guanidines; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Neuroendocrine Tumors; Xenograft Model Antitumor Assays | 2005 |